Business Description

Description
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FR?, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 1.75
Equity-to-Asset 0.69
Debt-to-Equity 0.38
Debt-to-EBITDA -0.59
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -60.9
3-Year EPS without NRI Growth Rate -28.4
3-Year FCF Growth Rate -6.7
Name Current Vs Industry Vs History
5-Day RSI 48.15
9-Day RSI 45.03
14-Day RSI 44.22
6-1 Month Momentum % 46.8
12-1 Month Momentum % -13.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.22
Quick Ratio 15.22
Cash Ratio 14.24

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.7
Shareholder Yield % -46.72
Name Current Vs Industry Vs History
ROE % -54.53
ROA % -39.35
ROIC % -47.19
ROC (Joel Greenblatt) % -87.21
ROCE % -40.09

Financials (Next Earnings Date:2024-05-10 Est.)

TIL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TIL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Instil Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -24
Beta 1.26
Volatility % 65.8
14-Day RSI 44.22
14-Day ATR ($) 0.393601
20-Day SMA ($) 10.7165
12-1 Month Momentum % -13.29
52-Week Range ($) 6.07 - 14
Shares Outstanding (Mil) 6.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Instil Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Instil Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Instil Bio Inc Frequently Asked Questions

What is Instil Bio Inc(TIL)'s stock price today?
The current price of TIL is $10.60. The 52 week high of TIL is $14.00 and 52 week low is $6.07.
When is next earnings date of Instil Bio Inc(TIL)?
The next earnings date of Instil Bio Inc(TIL) is 2024-05-10 Est..
Does Instil Bio Inc(TIL) pay dividends? If so, how much?
Instil Bio Inc(TIL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1